mir-148a promoted cell proliferation by targeting p27 in gastric cancer cells

International Journal of Biological Sciences

Volumn 7, Issue 5, 2011, Pages 567-574

  Guo, Shui Long ^a   Peng, Zheng ^b   Yang, Xue ^a,c   Fan, Kai Ji ^a   Ye, Hui ^a,c   Li, Zhen Hua ^a   Wang, Yan ^d   Xu, Xiao Li ^d   Li, Jun ^a   Wang, You Liang ^a   Teng, Yan ^a   Yang, Xiao ^a,c  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Cell proliferation; Gastric cancer; mir 148a; p27

Indexed keywords

EID: 79960116106     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.7.567     Document Type: Article

References (19)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2): 74-108.
2. Nobili S, Bruno L, Landini I, et al. Genomic and genetic altera-tions influence the progression of gastric cancer. World J Gas-troenterol. 2010; 17(3): 290-9.
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2): 281-97.
4. Ueda T, Volinia S, Okumura H, et al. Relation between mi-croRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010; 11(2): 136-46.
5. Guo J, Miao Y, Xiao B, et al. Differential expression of mi-croRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol. 2009; 24(4): 652-7.
6. Li X, Zhang Y, Ding J, et al. Survival prediction of gastric cancer by a seven-microRNA signature. Gut. 2010; 59(5): 579-85.
7. Tchernitsa O, Kasajima A, Schafer R, et al. Systematic evalua-tion of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression. J Pathol. 2010; 222(3): 310-9.
8. Tsukamoto Y, Nakada C, Noguchi T, et al. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res. 2010; 70(6): 2339-49.
9. Chen Y, Song Y, Wang Z, et al. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical signifi-cance. J Gastrointest Surg. 2010; 14(7): 1170-9.
10. Braconi C, Huang N, and Patel T. MicroRNA-dependent regu-lation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangio-cytes. Hepatology. 2010; 51(3): 881-90.
11. Fujita Y, Kojima K, Ohhashi R, et al. MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression. J Biol Chem. 2010; 285(25): 19076-84.
12. Murata T, Takayama K, Katayama S, et al. miR-148a is an an-drogen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression. Prostate Cancer Prostatic Dis. 2010; 13(4): 356-61.
13. Lujambio A, Calin GA, Villanueva A, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A. 2008; 105(36): 13556-61.
14. Hummel R, Watson DI, Smith C, et al. Mir-148a Improves Re-sponse to Chemotherapy in Sensitive and Resistant Oesopha-geal Adenocarcinoma and Squamous Cell Carcinoma Cells. J Gastrointest Surg. 2011 Mar;15(3):429-38.
15. Chu IM, Hengst L, and Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anti-cancer therapy. Nat Rev Cancer. 2008; 8(4): 253-67.
16. Haflidadottir BS, Bergsteinsdottir K, Praetorius C, et al. miR-148 regulates Mitf in melanoma cells. PLoS One. 2010; 5(7): e11574.
17. Song YX, Yue ZY, Wang ZN, et al. MicroRNA-148b is fre-quently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol Cancer. 2010; 10: 1.
18. Sun Q, Zhang Y, Yang G, et al. Transforming growth fac-tor-beta-regulated miR-24 promotes skeletal muscle differenti-ation. Nucleic Acids Res. 2008; 36(8): 2690-9.
19. Obernosterer G, Martinez J, and Alenius M. Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sec-tions. Nat Protoc. 2007; 2(6): 1508-14.